神経精神医学講座
Neuropsychiatry

◆ 著
1)

教 授

鈴木 道雄

Michio Suzuki

准教授

住吉 太幹

Tomiki Sumiyoshi

講 師

川﨑 康弘

Yasuhiro Kawasaki

講 師

角田 雅彦

Masahiko Tsunoda

助 教

岩田 卓也

Takuya Iwata

助 教

高橋 努

Tsutomu Takahashi

助 教

田仲 耕大

Kodai Tanaka

助 教

中村 主計

Kazue Nakamura

助 教

松岡 理

Tadasu Matsuoka

書Sumiyoshi C., and Sumiyoshi T.: Semantic memory deficits in schizophrenia, In Schizophrenic Psychology; New Research, by
French D.P. (Ed) 255-279, Nova Science Publishers Inc., Hauppauge, NY, USA, 2008.

2)

川﨑康弘, 鈴木道雄: 脳画像検査の臨床応用. 「精神疾患の脳画像解析・診断学」平安良雄, 笠井清登編, 114-122, 南
山堂, 東京, 2008.

3)

鈴木道雄: 統合失調症の脳構造診断の実用化. 「専門医のための精神科臨床リュミエール 2. 精神疾患と脳画像」福
田正人編, 192-204, 中山書店, 東京, 2008.

4)

鈴木道雄: 前駆期における生物学的診断. 「専門医のための精神科臨床リュミエール 5. 統合失調症の早期診断と早期介入」水野雅文編, 60-71, 中山書店, 東京, 2009.

◆ 原
1)

著

Higuchi Y., Sumiyoshi T., Kawasaki Y., Itoh T., Matsui M., Arai H., and Kurachi M.: Electrophysiological basis for the abilityof olanzapine to improve verbal memory and functional outcome in patients with schizophrenia: A LORETA analysis of P300.
Schizophr. Res., 101:320-30, 2008.

2)

Kawasaki Y., Suzuki M., Takahashi T., Nohara S., McGuire P.K., Seto H., and Kurachi M.: Anomalous cerebral asymmetry inpatients with schizophrenia demonstrated by voxel-based morphometry. Biol. Psychiatry, 63: 793-800, 2008.

3)

Matsui M., Sumiyoshi T., Arai H., Higuchi Y., and Kurachi M.: Cognitive functioning related to quality of life in schizophrenia.
Prog. Neuropsychopharmacol. Biol. Psychiatry, 32: 280-287, 2008.

4)

Matsui M., Suzuki M., Zhou S.-Y., Takahashi T., Kawasaki Y., Yuuki H., Kato K., and Kurachi M.: Prefrontal brain volume andcharacteristics of memory strategy in schizophrenia spectrum disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry,
32:1854-1862, 2008.

5)

Matsuoka T., Tsunoda M., Sumiyoshi T., Takasaki I., Tabuchi Y., Seo T., Tanaka K., Uehara T., Itoh H., Suzuki M., and Kurachi
M.: Effect of MK-801on gene expressions in the amygdala of rats. Synapse, 62:1-7, 2008.

6)

Meltzer H.Y., and Sumiyoshi T.: Does stimulation of 5-HT1A receptors improve cognition in schizophrenia? Behav. Brain Res.,
195:98-102, 2008.

7)

Murata M., Tsunoda M., Sumiyoshi T., Sumiyoshi C., Matsuoka T., Suzuki M., Ito M., and Kurachi M.: Calcineurin A gamma
and B gene expressions in the whole blood in Japanese patients with schizophrenia. Prog. Neuropsychopharmacol. Biol.
Psychiatry, 32: 1000-1004, 2008.

8)

Seo T.*, Sumiyoshi T., Tsunoda M., Tanaka K., Uehara T., Matsuoka T., Itoh H., and Kurachi M.: T-817 a novel neurotrophic
compound, ameliorates phencyclidine-induced disruption of sensorimotor gating. Psychopharmacology, 197: 457-464, 2008.

9)

Sumiyoshi T., Matsui M., Itoh H., Higuchi Y., Arai H., Takamiya C. and Kurachi M.: Essential polyunsaturated fatty acids andsocial cognition in schizophrenia. Psychiatry Res., 157: 87-93, 2008.

10) Sumiyoshi T., Bubenikova-Valesova V., Horacek J., and Bert B.: Serotonin1A receptors in the pathophysiology ofschizophrenia: Development of novel cognition-enhancing therapeutics. Adv. Ther., 25:1037-1056, 2008.

11) Takahashi T., Suzuki M., Nakamura K., Tanino R., Zhou S.-Y., Hagino H., Niu L., Kawasaki Y., Seto H., and Kurachi M.:
Association between absence of the adhesio interthalamica and amygdala volume in schizophrenia. Psychiatry Res.
Neuroimaging, 162: 101-111, 2008.
12) Takahashi T., Suzuki M., Tsunoda M., Kawamura Y., Takahashi N., Tsuneki H., Kawasaki Y., Zhou S.-Y., Kobayashi S.,
Sasaoka T., Seto H., Kurachi M., and Ozaki N.: Association between the brain-derived neurotrophic factor Val66Met
polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons. Neurosci. Lett., 435:
34-39, 2008.
13) Takahashi T., Suzuki M., Tsunoda M., Kawamura Y., Takahashi N., Maeno N., Kawasaki Y., Zhou S.-Y., Hagino H., Niu L.,
Tsuneki H., Kobayashi S., Sasaoka T., Seto H., Kurachi M., and Ozaki N.: The association of genotypic combination of the
DRD3 and BDNF polymorphisms on the adhesio interthalamica and medial temporal lobe structures. Prog.
Neuropsychopharmacol. Biol. Psychiatry, 32: 1236–1242, 2008.
14) Takahashi T., Suzuki M., Zhou S.-Y., Nakamura K., Tanino R., Kawasaki Y., Seal M.L., Seto H., and Kurachi M.: Prevalence
and length of the adhesio interthalamica in schizophrenia spectrum disorders. Psychiatry Res. Neuroimaging, 164: 91-95, 2008.
15) Takahashi T., Yücel M., Yung A.R., Wood S.J., Phillips L.J., Berger G.E., Ang A., Soulsby B., McGorry P.D., Suzuki M.,
Velakoulis D., and Pantelis C.: Adhesio interthalamica in individuals at high-risk for developing psychosis and patients withpsychotic disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry, 32: 1708-1714, 2008.
16) Takahashi T., Yung A.R., Yücel M., Wood S.J., Phillips L.J., Harding I.H., Soulsby B., McGorry P.D., Suzuki M., Velakoulis D.,
and Pantelis C.: Prevalence of large cavum septi pellucidi in ultra high-risk individuals and patients with psychotic disorders.
Schizophr. Res., 105: 253-261, 2008.
17) 兼田康宏, 住吉太幹, 中込和幸, 沼田周助, 田中恒彦, 上岡義典, 大森哲郎, Keefe R.S.E.: 統合失調症認知機能簡易評価尺度日本語版(BACS-J). 精神医学, 50: 913-917, 2008.
18) 松井三枝, 三村將, 田渕肇, 加藤奏, 鈴木道雄, 葛野洋一: 日本版前頭葉性行動質問紙 Frontal Behavioral Inventory(FBI)の作成.高次脳機能研究, 28:373-382, 2008.
19) 豊田満生*, 松井三枝, Gur R.C., 住吉太幹, 田仲耕大, 樋口悠子, 鈴木道雄, 倉知正佳: 気分障害における表情認知の研究. 精神医学, 50: 1069-1077, 2008.

◆ 症例報告1)

古市厚志*, 角田雅彦, 鈴木道雄: 集中内観中に自殺企図に至ったうつ病患者の一例．内観研究，14:59-66，2008.

2)

佐是礼奈, 中村主計, 古市厚志, 上原隆, 角田雅彦, 鈴木道雄: 22q11.2 欠失症候群に脳波異常を伴った１例. 精神科,
13: 270-274, 2008.

◆ 総
1)

説

Sumiyoshi T., Kawasaki Y., Suzuki M., Higuchi Y., Nishiyama S., and Kurachi M.: Neurocognitive assessment andpharmacotherapy towards prevention of schizophrenia: What can we learn from first episode psychosis? ClinicalPsychopharmacology and Neuroscience, 6:57-64, 2008.

2)
3)

Sumiyoshi T.: A possible dose-side effect relationship of antipsychotics: Relevance to cognitive function in schizophrenia.
Expert Review of Clinical Pharmacology, 1:791-812, 2008.
Uehara T., Sumiyoshi T., Itoh H., and Kurata K.: Lactate production and neurotransmitters; Evidence from microdialysis
studies. Pharmacol. Biochem. Behav., 90:273-281, 2008.

4)

Yui K., Suzuki M., and Kurachi M.: Stress sensitization in schizophrenia. Ann. N.Y. Acad. Sci., 1113: 276-290, 2007.

5)

加藤 奏, 松井三枝, 結城博実, 倉知正佳, 鈴木道雄: 初期アルツハイマー病の神経心理学的特徴とBrief-Neuropsychological Scale (BNPS). Dementia Japan, 21: 215-224, 2007.

6)鈴木道雄: 統合失調症の脳病態－形態画像診断によってわかったこと－. 北陸精神神経医学雑誌, 21(2): 11-16, 2007.

7)

鈴木道雄, 倉知正佳: 統合失調症の二段階仮説. Schizophr. Front., 8: 235-238, 2008.

8)鈴木道雄: 統合失調症の脳病態に即した早期診断・早期治療の実現のために. 富山大学医学会誌, 18:21-24, 2008.

9)鈴木道雄, 高橋 努, 周 世昱, 川﨑康弘, 角田雅彦, 倉知正佳: 統合失調症―脳画像研究からみた発病脆弱性と統合失調症型障害における顕在発症防御機構―. 臨床精神医学, 37: 377-384, 2008.

10) 鈴木道雄: 脳の形態から統合失調症を明らかにする. ビオフィリア, 4: 41-45, 2008.
11) 鈴木道雄: 統合失調症早期介入における鍵概念の意義と課題. MARTA, 6: 13-16, 2008.

12) 高橋 努, 鈴木道雄: 気になる脳部位: 島. 分子精神医学, 8: 357-360, 2008.

◆ 学会報告
1)

2)

3)

4)

5)

6)

7)

8)
9)
10)

11)

12)

13)

14)

15)

Higuchi Y., Sumiyoshi T., Kawasaki Y., Itoh T., Matsui M., Arai H., and Kurachi M.: Electrophysiological basis for the abilityof olanzapine to improve verbal memory and functional outcome in patients with schizophrenia: A LORETA analysis of P300.
World Federation of Societies of Biological Psychiatry - The 2nd WFSBP Asia-Pacific Congress, 2008, 9, 13, Toyama.
Kawasaki Y., Sumiyoshi T., Higuchi Y., Ito T., Takeuchi M., Kurachi M., and Suzuki M.: Voxel-based analysis of P300
elecctrophysiological topography associated with positive and negative symptoms of schizophrenia. The 14th Biennial WinterWorkshop on Schizophrenia and Bipolar Disorders, 2008, 2, 3-7, Montreux, Switzerland.
Kawasaki Y., Suzuki M., Sumiyoshi T., Takahashi T., Nishiyama S., Matsui M., Kurachi M., and Kazukawa S. Implementing
clinical service for young people at risk of developing psychosis in toyama japan. The 14th Biennial Winter Workshop on
Schizophrenia and Bipolar Disorders, 2008, 2, 3-7, Montreux, Switzerland.
Kawasaki Y., Suzuki1 M., Takahashi T., and Nohara S., Nakamura K., Kurachi M.: Anomalous cerebral asymmetry in patientswith schizophrenia demonstrated by voxel-based morphometry. 1st Schizophrenia International Research Society Conference,
2008, 6, 21-25, Venice.
Kawasaki Y.: Structural Neuroimaging as a Biomarker for Schizophrenia. In symposium (organized and chaired by Kozima T.
and Kawasaki Y.): Novel Biomarkers for Schizophrenia and Depressive Disorders. The 2nd WFSBP Asia-Pacific Congress and30th Annual Meeting of JSBP, 2008, 9, 11-13, Toyama.
Kawasaki Y., Suzuki M., Takahashi T., Sumiyoshi T., Nishiyama S., Matsui M., Kurachi M., and Kazukawa S.: Early detection
and intervention project for young people at risk for developing psychosis in Toyama. 21st October the 6th International
Conference on Early Psychosis, 2008, 10, 21, Melbourne , Australia.
Kawasaki Y., Suzuki M., Takahashi T., Sumiyoshi T., McGuire P.K., and Kurachi M.: Voxel-Based Morphometry Evaluating
Gray Matter Asymmetry in Patients with Schizophrenia. 10th Biennial Australasian Schizophrenia Conference, 2008, 10, 23,
Lorne, Australia.
Matsui M., Sumiyoshi T., Arai H., Higuchi Y., and Kurachi M. : Cognitive functioning related to quality of life in patients withschizophrenia. 36th Annual Meeting of International Neuropsychological Society, 2008, 2, 7, Kona, Hawaii.
Matsui M., Suzuki M., Zhou S.-Y., Takahashi T., Kawasaki Y., and Kurachi M : Prefrontal brain volume and characteristics ofmemory strategy in schizophrenia spectrum disorder. 7th Tsukuba International Conference on Memory, 2008, 3, 21, Tsukuba.
Matsui M., Suzuki M., Zhou S.-Y., Takahashi T., Kawasaki Y., Yuuki H., Kato K., and Kurachi M,: Prefrontal Brain Volume
and Characteristics of Memory Strategy in Schizophrenia Spectrum Disorder. Symposium “Neuropsychology and
Neuroimaging Approach to Memory Function in Schizophrenia Spectrum Disorders”. 2nd WFSBP Asia-Pacific Congress and30th Annual Meeting of JSBP, 2008, 9, 11, Toyama.
Matsui M., Arai H., Yonezawa M., Sumiyoshi T., Suzuki M., and Kurachi M.: Effects of cognitive rehabilitation on social
knowledge in patients with schizophrenia. World Federation of Societies of Biological Psychiatry - The 2nd WFSBP
Asia-Pacific Congress, 2008, 9, 13, Toyama.
Matsui M., Arai H., Yonezawa M., Sumiyoshi T., Suzuki M., and Kurachi M. : Effect of cognitive rehabilitation focused on
deficits of social knowledge in patients with schizophrenia. National Academy of Neuropsychology 28th Annual Conference,
2008, 10, 22-25, New York.
Matsuoka T., Tsunoda T., Sumiyoshi T., Takasaki I., Tabuchi Y., Tanaka K., Uehara T., Itoh H., Suzuki M., and Kurachi M.:
Effect of MK-801 on gene expression in the amygdala of rats. Collegium Internationale Neuro-Psychopharmacologicum – 26th
CINP Congress, 2008,7, Munich, Germany.
Matsuoka T., Tsunoda M., Sumiyoshi T., Takasaki I., Tabuchi Y., Seo T., Tanaka K., Uehara T., Itoh H., Suzuki M., and Kurachi
M.: Effect of MK-801 on gene expressions in the amygdala of rats. World Federation of Societies of Biological Psychiatry The 2nd WFSBP Asia-Pacific Congress, 2008, 9, 11, Toyama.
Mizuno M., Suzuki M., Matsumoto K., Takeshi K., and Murakami M.: The status quo of early intervention in Japan. In
symposium: Early Psychosis Developments in East and South East Asia. 6th International Conference on Early Psychosis, 2008,
10, 20-22, Melbourne, Australia.

16) Mizuno M., Suzuki M., Matsumoto K., Murakami M., Takeshi K., Miyakoshi T., Ito F., Yamazawa R., Kobayashi H., NemotoT., and Kurachi M.: Early detection and intervention for schizophrenia in Japan. In symposium: Early Detection of
Schizophrenia in East Asia. 13th Pacific Rim College of Psychiatrists Scientific Meeting, 2008, 10, 30-11, 1, Tokyo.
17) Nishiyama S., Takahashi T., Tanino R., Tsunoda M., Matsui M., Kawasaki Y., Suzuki M., and Kurachi M.: Development andValidation of a Self-disturbance Scale for Schizophrenia. 2nd WFSBP (World Asia-Pacific Congress) and 30th Annual Meetingof JSBP (Japanese Society of Biological Psychiatry), 2008, 9, 11-13, Toyama.
18) Nishiyama S., Takahashi T., Tanino R., Tsunoda M., Matsui M., Kawasaki Y., Suzuki M., and Kurachi M.: Development of a
Self-disturbance Scale from the Minnesota Multiphasic Personality Inventory.
Psychosis, 2008, 10, 20-22, Melbourne, Australia.

6th International Conference on Early19) Seo T., Sumiyoshi T., Tsunoda M., Tanaka K., Uehara T., Matsuoka T., Itoh H., and Kurachi M.: T-817 a novel neurotrophic
compound, ameliorates phencyclidine-induced disruption of sensorimotor gating. World Federation of Societies of BiologicalPsychiatry - The 2nd WFSBP Asia-Pacific Congress, 2008, 9, 11, Toyama.
20) Sumiyoshi C., and Sumiyoshi T.: Linguistic variability in the performance on verbal fluency tasks in schizophrenia. In
Symposium “Cognitive impairment in schizophrenia: Neurobiology and therapeutic intervention” (Organized by Sumiyoshi T.);
World Federation of Societies of Biological Psychiatry - The 2nd WFSBP Asia-Pacific Congress, 2008, 9, 12, Toyama. (Invited
speaker)21) Sumiyoshi C., Ertugrul A., Anil Yacgioglu, A.E., Roy A., Jayathilake K., Meltzer H.Y., and Sumiyoshi T.: Language-dependent
performance on the verbal fluency task in schizophrenia: A cross-linguistic study. World Federation of Societies of BiologicalPsychiatry - The 2nd WFSBP Asia-Pacific Congress, 2008, 9, 13, Toyama.
22) Sumiyoshi T., Uehara T., Matsuoka T., Higuchi Y., Ito T., and Meltzer H. Y.: Serotonin-1A agonists as a cognitive enhancer inschizophrenia: Clinical evidence. In Symposium “The Role of 5-HT1A Receptors in the Pathophysiology and Treatment of
Schizophrenia”; 16th European Congress of Psychiatry, 2008, 4, 8, Nice, France. (Invited speaker)23) Sumiyoshi T.: Role of serotonin-1A receptors in the treatment of memory disturbances in schizophrenia: Evidence fromtranslational research. In Workshop “Memory and Schizophrenia: Molecular, Pharmacological and Neurocognitive
Perspectives”; Society of Biological Psychiatry – 63rd Annual Meeting, 2008. 5. 1. Washington DC. (Invited speaker)24) Sumiyoshi T., Higuchi Y., Kawasaki Y., Ito T., Tsunoda M., and Suzuki M.: P300 current source imaging as a feasible
biomarker for treatment response in schizophrenia. In Symposium “Recent neurophysiological advances in biologicalpsychiatry”; World Federation of Societies of Biological Psychiatry - The 2nd WFSBP Asia-Pacific Congress, 2008, 9, 11,
Toyama. (Invited speaker)25) Sumiyoshi T., Sumiyoshi C., Ertugrul A., Park S., and Meltzer H.Y..: Serotonin-1A receptors in the action of antipsychotic
drugs – Neurocognitive perspectives. In Symposium “Pharmacotherapy and long-term outcome in schizophrenia: Evidence
from translational research” (Organized and chaired by Sumiyoshi T.); World Federation of Societies of Biological Psychiatry The 2nd WFSBP Asia-Pacific Congress, 2008, 9, 12, Toyama. (Invited speaker)
26) Sumiyoshi T., Park S., Jayathilake K., Roy A. and and Meltzer H.Y.: Effect of buspirone, a serotonin 1A partial agonist, on
cognitive function in schizophrenia: A randomized double-blind placebo-controlled study. 16th European Congress of
Psychiatry, 2008, 4, 8, Nice, France.
27) Sumiyoshi T., Higuchi Y., Kawasaki Y., Arai H., Matsui M., and Kurachi M.: Electrophysiological basis for the ability ofolanzapine to improve verbal memory and functional outcome in patients with schizophrenia. Collegium Internationale
Neuro-Psychopharmacologicum – 26th CINP Congress, 2008.7, Munich, Germany.
28) Suzuki M., Kawasaki Y., Takahashi T., Sumiyoshi T., Nishiyama S., Matsui M., Kurachi M., and Kazukawa S.: Earlyintervention project in Toyama and structural brain imaging in early psychosis. In symposium (organized and chaired by SuzukiM.): Early Psychosis: Clinical and Neurobiological Perspectives. The 2nd WFSBP Asia-Pacific Congress and 30th Annual
Meeting of JSBP, 2008, 9, 11-13, Toyama.
29) Suzuki M.: Longitudinal volume changes in parcellated prefrontal and superior temporal cortices in first-episode patients withschizophrenia, patients with schizotypal disorder, and healthy subjects. Workshop on Progressive Brain Change as a Satellite of
ACNP 47th Annual Meeting.2008, 12, 12, Scottsdale. (invited lecture).
30) Suzuki M., Kawasaki Y., Takahashi T., Sumiyoshi T., Nishiyama S., Arai H., Matsui M., Kurachi M., and Kazukawa S.: Early
detection and intervention project for people at risk for developing psychosis in Toyama. 1st Schizophrenia International
Research Society Conference, 2008, 6, 21-25, Venice Italy.
31) Takahashi T., Suzuki M., Nakamura K., Tanino R., Zhou S.-Y., Kawasaki Y., Hagino H., Niu L., Seto H., and Kurachi M.:
Relationships between cerebral midline abnormalities and volumes of the medial temporal lobe structures in patients withschizophrenia. XIVth Biennial Winter Workshop on Schizophrenia and Bipolar Disorders, 2008, 2, 3-7, Montreux, Switzerland.
32) Takahashi T., Nakamura K., Suzuki M., Zhou S.Y., Kawasaki Y., Seto H., and Kurachi M.: Prevalence and length of the adhesio
interthalamica in schizophrenia spectrum. 2nd World Federation of Societies of Biological Psychiatry Asia-Pacific Congressand 30th Annual Meeting of Japanese Society of Biological Psychiatry, 2008, 9, 11-13, Toyama, Japan.
33) Takahashi T., Tsunoda M., Suzuki M., Kawamura Y., Takahashi N., Kawasaki Y., Zhou S.Y., Tsuneki H., Kobayashi S., Sasaoka
T., Seto H., Kurachi M., and Ozaki N.: Association between the BDNF Val66Met polymorphism and brain morphology inschizophrenia. 2nd World Federation of Societies of Biological Psychiatry Asia-Pacific Congress and 30th Annual Meeting ofJapanese Society of Biological Psychiatry, 2008, 9, 11-13, Toyama, Japan.
34) Takahashi T., Tsunoda M., Suzuki M., Kawamura Y., Takahashi N., Maeno N., Kawasaki Y., Zhou S.Y., Tsuneki H., Kobayashi
S., Sasaoka T., Seto H., Kurachi M., and Ozaki N.: Genotypic interaction effect of DRD3 and BDNF on the adhesio
interthalamica and hippocampus. 2nd World Federation of Societies of Biological Psychiatry Asia-Pacific Congress and 30th
Annual Meeting of Japanese Society of Biological Psychiatry, 2008, 9, 11-13, Toyama, Japan.

35) Takahashi T., Wood SJ., Yung AR., Soulsby B., McGorry PD., Suzuki M., Phillips LJ., Velakoulis D., and Pantelis C.:
Progressive Gray Matter Reduction of the Superior Temporal Gyrus during Transition to Psychosis. 6th International
36)

37)

38)

39)

40)

41)

42)
43)
44)

45)

Conference on Early Psychosis. 10, 20-22, Melbourne, Australia.
Uehara T., Sumiyoshi T., Matsuoka T., Itoh H., and Kurachi M.: Role of prefrontal cortex in the modulation of subcortical
dopaminergic activity in an animal model of schizophrenia. In Symposium “Frontal and temporal lobes in the pathophysiology
of schizophrenia” (Organized by Sumiyoshi T.); World Federation of Societies of Biological Psychiatry - The 2nd WFSBP
Asia-Pacific Congress, 2008, 9, 11, Toyama. (Invited speaker)
Uehara T., Sumiyoshi T., Matsuoka T., and Suzuki M.: A novel view of the pathophysiology of psychiatric disorders anddevelopment of pharmacotherapy based on brain energy metabolism. EHRLICH II – 2nd World Conference on Magic Bullets,
2008, 10, 4, Nurnberg, Germany. (Invited speaker)
Uehara T., Sumiyoshi T., Itoh H., Kurachi M., and Matsuoka T.: Lactate production and neurotransmitters; (1) Role ofglutamate transporters in the modulation of stress-induced lactate metabolism in the rat brain. Collegium Internationale
Neuro-Psychopharmacologicum – 26th CINP Congress, 2008.7, Munich, Germany.
Uehara T., Sumiyoshi T., Itoh H., Kurachi M., and Matsuoka T.: Lactate production and neurotransmitters; (2) Dopamine D1
and D2 receptors regulate extracellular glucose and lactate concentrations in the nucleus accumbens in the rat. CollegiumInternationale Neuro-Psychopharmacologicum – 26th CINP Congress, 2008.7, Munich, Germany.
Uehara T., Sumiyoshi T., Itoh H., Kurachi M., and Matsuoka T.: Lactate production and neurotransmitters; (2) Dopamine D1
and D2 receptors regulate extracellular glucose and lactate concentrations in the nucleus accumbens in the rat. CollegiumInternationale Neuro-Psychopharmacologicum – 26th CINP Congress, 2008.7, Munich, Germany.
Uehara T., Sumiyoshi T., Matsuoka T., Itoh H., Suzuki M., and Kurata K.: Role of glutamate transporters in the modulation ofstress-induced lactate metabolism in the rat brain. World Federation of Societies of Biological Psychiatry - The 2nd WFSBP
Asia-Pacific Congress, 2008, 9, 13, Toyama.
古市厚志*, 角田雅彦, 鈴木道雄: 集中内観を導入後に双極Ⅱ型障害と診断した一例．
第 11 回日本内観医学会，2008，
10，4，鹿児島．
伊東 徹*, 住吉太幹, 樋口悠子, 川崎康弘, 角田雅彦, 鈴木道雄: 統合失調症認知機能簡易評価尺度―日本語版(BACS-J)を用いた統合失調症の認知機能評価 ―富山大学での試み―. 第 169 回北陸精神神経学会, 2008, 1, 27, 金沢.
Kawasaki Y., Suzuki M., Sumiyoshi T., Takahashi T., Iwata T., Tanaka K., Higuchi Y., Ito T., Matsui M., Kurachi M., andKazukawa S.: Clinical service for young people at risk of developing psychosis in Toyama. 第 3 回日本統合失調症学会,
2008, 3, 15, 東京.
Kawasaki Y., Suzuki M., Takahashi T., Nohara S., Nakamura K., and Kurachi M.: A disturbed cerebral asymmetry inlanguage-related regions of patients with schizophrenia. 第 3 回日本統合失調症学会, 2008, 3, 15, 東京.
46) 川﨑康弘, 鈴木道雄, 高橋 努, 中村主計, 西山志満子, 倉知正佳, 數川 悟: 統合失調症前駆期における脳画像診断．
シンポジウム：統合失調症早期介入の意義と実際．第 104 回 日本精神神経学会、2008, 5, 30, 東京.
47) 川﨑康弘, 樋口悠子, 佐是礼奈, 鈴木道雄: リエゾン外来における入院がん患者の治療について．第 21 回 日本サイ
コオンコロジー学会, 2008, 10, 9, 東京.
川崎康弘, 住吉太幹, 樋口悠子, 伊東 徹, 竹内正志, 古市厚志, 鈴木道雄: 事象関連電位と機能的磁気共鳴画像を用いた相貌認知過程の時空間的解析. 第 38 回日本臨床神経生理学会学術大会, 2008, 11, 12, 神戸.
49) 松井三枝, 荒井宏文, 米澤峰男, 住吉太幹, 倉知正佳: 統合失調症患者における認知リハビリテーションの開発とその効果研究. 第 4 回統合失調症研究会, 2008, 2, 16, 東京.
50) Matsui M., Sumiyoshi T., Arai H., Higuchi Y., Kurachi M.: Cognitive functioning related to quality of life in schizophrenia. 第３回日本統合失調症学会, 2008, 3, 15, 東京.
51) 松井三枝, 鈴木道雄, 周世昱, 高橋 努, 川崎康弘, 倉知正佳: 統合失調症圏患者における記憶方略の特徴と前頭葉体48)積の関連. 第 31 回日本神経科学大会, 2008, 7, 9, 東京.
52) 松井三枝, 荒井宏文, 米沢峰男, 住吉太幹, 鈴木道雄, 倉知正佳: 統合失調症患者への認知リハビリテーションの効
果研究. 第 32 回日本神経心理学会, 2008, 9, 19, 東京.
53) 松井三枝, 荒井宏文, 西山志満子, 古市厚志, 高橋努, 中村主計, 川崎康弘, 住吉太幹, 鈴木道雄, 倉知正佳: 統合失調症の補助診断法としての神経心理学的評価の有用性. 第 8 回精神疾患と認知機能研究会, 2008, 11, 8, 東京.
54) Matsuoka T., Tsunoda M., Sumiyoshi T., Takasaki I., Tabuchi Y., Seo T., Tanaka K., Uehara T., Itoh H., Suzuki M., Kurachi M.:
Effect of MK-801on gene expressions in the amygdala of rats. 第３回日本統合失調症学会, 2008, 3, 15, 東京.
55) 松岡 理, 上原 隆, 高橋 努, 古市厚志, 宮 一志, 野村恵子, 金兼弘和, 角田雅彦, 住吉太幹, 鈴木道雄. 松果体部脳腫瘍の治療中に急性錯乱状態を繰り返した一例. 第 13 回日本神経精神医学会, 2008, 11, 27-28, 金沢.
56) 西山志満子, 高橋 努, 谷野亮一郎, 松井三枝, 角田雅彦, 川崎康弘, 鈴木道雄, 倉知正佳: ミネソタ多面人格目録（MMPI）の自我障害尺度の開発 第 3 報 －統合失調症の早期診断のために－ 第 28 回日本精神科診断学会，
2008, 10, 10-11, 札幌．
57) 西山志満子, 高橋 努, 谷野亮一郎, 角田雅彦, 松井三枝, 川崎康弘, 鈴木道雄, 倉知正佳: 自我障害尺度の開発とハ
イリスク群への適用の試み．第 12 回日本精神予防研究会, 2008, 12, 14 東京．

58) 瀬尾友徳, 住吉太幹, 角田雅彦, 田仲耕大, 上原 隆, 松岡 理, 伊藤博子, 鈴木道雄, 倉知正佳: 神系栄養作用をもつ
T-817 は、phencyclidine 投与による sensorimotor gating の障害を改善する. 第 18 回日本臨床精神神経薬理学会・第 38
回日本神経精神薬理学会合同年会, 2008, 10, 10, 東京.
59) 住吉チカ, 山下委希子, 住吉太幹: 発達障害児の知識構造について：語流調性課題による検討. 第 72 回日本心理学会,
2008, 9, 19, 札幌.
60) 鈴木正泰, 松島英介, 小島卓也, 高橋 栄, 内山 真, 角田雅彦, 倉知正佳, 大塚達以, 平安良雄, 荒川亮介, 大久保善朗, 石井洋平, 森田喜一郎, 岡田 俊, 林 拓二, 片山征爾, 木下真衣, 太田克也: 探索眼球運動を用いた統合失調症の客観的診断. 第 475 回日大医学会, 2008, 東京.
61) 鈴木道雄: 統合失調症の脳病態と神経発達. シンポジウム: 統合失調症の基本病態仮説. 第 3 回日本統合失調症学会,
2008, 3, 14-15, 東京.（招待講演）
62) 竹内正志*, 古田壽一, 細川宗仁, 落合容子, 佐藤秋雄, 栗田俊治, 鈴木道雄, 倉知正佳, 松井三枝: 記憶の組織化に対する夜間睡眠の効果 ―睡眠徐波成分との関連について―, 日本睡眠学会第 33 回定期学術集会, 2008, 6, 25-26, 福島.
63) 竹内正志*, 古田壽一, 細川宗仁, 落合容子, 佐藤秋雄, 鈴木道雄, 倉知正佳, 松井三枝: 記憶の組織化に及ぼす夜間睡眠の効果について. 近畿睡眠研究会, 2008, 3, 15, 京都.
64) 角田雅彦, 鈴木道雄, 倉知正佳：「富山うつプロジェクト」患者アンケート調査について. 第 169 回北陸精神神経学会, 2008, 1, 金沢.

◆ その他
1)

2)
3)
4)
5)

福田正人, 中根充文, 氏家 寛, 岡崎祐士, 針間博彦, 松岡洋夫, 中根秀之, 鹿島晴雄, 大久保善朗, 古川壽亮, 住吉太幹, 安西信雄, 大島 厳, 池淵恵美, 小川一夫, 谷井久志, 林 拓二, 松本英夫, 倉知正佳: 診断. 厚生労働省 精神・神経疾患研究委託費（18 指-7） 「統合失調症ガイドラインの作成とその検証に関する研究」, 2008, 12, 6, 東京.
小山 司, Meltzer H.Y. , 住吉太幹, 笠井清登, 黒木俊秀: 5-HT1A 受容体と抗精神病薬の作用機序. 臨床精神神経薬理,11: 1755-1772, 2008.
Meltzer H.Y., 小山 司, 住吉太幹: 統合失調症におけるセロトニン神経系の役割. 臨床精神神経薬理, 11: 2175-2185,2008.
住吉太幹, Meltzer H.Y., 小山 司: セロトニン 5-HT1A 受容体の可能性：5-HT1A 受容体と抗精神病薬の作用機序. 臨
床精神神経薬理, 11: 2159-2167, 2008.
住吉太幹, 樋口悠子, 川崎康弘, 伊東 徹, 角田雅彦, 鈴木道雄: P300 current source imaging as a feasible biomarker fortreatment response in schizophrenia. 第 41 回精神神経系薬物治療研究報告会. 2008, 10, 大阪.

6)

鈴木道雄: 統合失調症における脳形態変化と早期介入. こころの臨床学会会誌, NO.20, 1-4, 2008.

7)鈴木道雄: 早期診断・早期治療の充実により精神疾患の長期予後改善へ. 医報とやま No. 1448, 6-7, 2008.

8)鈴木道雄: Talk 大学病院は今、「富山大学大学院医学薬学研究部神経精神医学講座」. CONSONANCE 2008WINTER, 7-8,
2008.

9)

鈴木道雄: 大学病院研究室めぐり「富山大学大学院医学薬学研究部神経精神医学講座」. あさひ View, 16: 6-8, 2008.

10) 鈴木道雄: ストレスと心の健康. 精神保健福祉とやま. 第 27 号, 2-6, 2008.
11) 鈴木道雄: 非定型抗精神病薬の試験結果を読む: 精神病の前駆症状を示す患者における olanzapine の無作為化プラセ
ボ対照二重盲検試験. Schizophr. Frontr., 9: 209-212, 2008.
12) 鈴木道雄: 精神病早期介入は是か非か. 巻頭言. 精神医学, 50: 1144-1145, 2008.
13) 鈴木道雄: 「気分障害」書評. 精神医学, 50: 1234, 2008.
14) 鈴木道雄, 住吉太幹, 川崎康弘, 高橋 努, 樋口悠子, 倉知正佳: 脳画像解析による早期精神病の病態生理と客観的診断指標に関する研究(III). 厚生労働省 精神・神経疾患研究委託費「早期精神病の予防、早期治療および病態解明に関する臨床研究」研究報告会, 2008, 12, 15, 東京.
15) 鈴木道雄, 川﨑康弘, 住吉太幹, 高橋 努, 樋口悠子, 中村主計, 伊東 徹, 古市厚志, 瀬戸 光, 倉知正佳: 脳画像解析の応用による統合失調症の客観的補助診断と治療効果判定. 厚生労働省 精神・神経疾患研究委託費「精神疾患の客観的補助診断法の標準化と科学的根拠に基づく治療反応性の判定法の確立に関する研究」研究報告会, 2008, 12, 17,
東京.